Fundraising FoxEcoR1 Capital — 2021 Investments
4 investments dated 2021 · listed companies and verified rows first · show all
ReCode develops mRNA and gene correction therapeutics for genetic diseases, using proprietary lipid nanoparticle technology to deliver treatments to specific organs.
AI & Machine LearningBiotechHealthtechMedical DevicesMenlo Park, US
Dr. Daniel J. SiegwartArthur E Johnson(Executive Officer, Director)
Board seatOleg Nodelman· per SEC Form D
Co-investorsAju IB InvestmentEvolution VC PartnersMPM BioImpactOrbiMedOUP (Osage University Partners)Pfizer Venture Investments+6 more
Cellares develops automated manufacturing systems and technology platforms to accelerate the production and commercialization of cell therapies.
Advanced ManufacturingBiotechMedical DevicesSouth San Francisco, US
Fabian Gerlinghaus(Founder)inOmar Kurdi(Founder)inAlex Pesch(Founder)Fabian Gerlinghaus Omar Kurdi(Founder)
BoardJustin Butler(Director)inVictor Tong(Director)in
Co-investorsDecheng Capital8VCIntuitive VenturesKoch Disruptive TechnologiesBaillie GiffordBlackRock+4 more
Kumquat Biosciences is a biotech company developing small-molecule cancer therapeutics, combining drug discovery and clinical expertise to advance new oncology treatments.
BiotechSan Diego, US
Yi Liu(Executive Officer, Director)inYi Liu, Ph.D.(CEO)Lynn Yang(Director)
BoardCarl Gordon(Director)in
Co-investorsOrbiMedRoche Venture Fund
NiKang Therapeutics is a clinical-stage biotechnology company developing small molecule drugs for cancer, using structure-based drug design against targets such as HIF2α, CDK2, KRAS, and SHP2.
BiotechHealthtechWilmington, CN
Yan Lou(Founder)inZhenhai Gao(President, CEO, and Secretary)Hong (Kelsey) Chen(Chief Financial Officer)
BoardGary Yeung(Director)Ting Jia(Director)Roderick Wong(Director)
Co-investorsHBM Healthcare InvestmentsHBM PartnersLAVLilly Asia VenturesRA CapitalSamsara BioCapital+3 more
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.